GIP and diabetes mellitus: Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) exert their beneficial effects on diabetes through distinct G protein-coupled receptors, which are highly expressed on islet β cells [8].